Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Change in Cash: 2022-2023

Historic Change in Cash for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2023 value amounting to $86.0 million.

  • Lexeo Therapeutics' Change in Cash rose 611.58% to $86.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $44.1 million, marking a year-over-year change of. This contributed to the annual value of -$86.5 million for FY2024, which is 295.90% down from last year.
  • As of Q4 2023, Lexeo Therapeutics' Change in Cash stood at $86.0 million, which was up 952.50% from -$10.1 million recorded in Q3 2023.
  • Lexeo Therapeutics' Change in Cash's 5-year high stood at $86.0 million during Q4 2023, with a 5-year trough of -$18.5 million in Q1 2023.
  • In the last 2 years, Lexeo Therapeutics' Change in Cash had a median value of -$13.3 million in 2023 and averaged $5.5 million.
  • Data for Lexeo Therapeutics' Change in Cash shows a peak YoY soared of 611.58% (in 2023) over the last 5 years.
  • Lexeo Therapeutics' Change in Cash (Quarterly) stood at -$16.8 million in 2022, then spiked by 611.58% to $86.0 million in 2023.
  • Its Change in Cash stands at $86.0 million for Q4 2023, versus -$10.1 million for Q3 2023 and -$13.3 million for Q2 2023.